Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur J Clin Pharmacol. 2009 Nov;65(11):1063-70. doi: 10.1007/s00228-009-0714-8.

Blood-brain barrier transporters and response to CNS-active drugs.

Author information

1
Division of Clinical Pharmacology, Department of Medicine, University of Western Ontario, London, ON, Canada.

Abstract

BACKGROUND:

The capillary endothelial cells of the blood-brain barrier express an array of uptake and efflux drug transporters. Regulated expression and function of these transporters govern the central nervous system (CNS) penetration of essential nutrients, therapeutic drugs and, in some cases, toxins. Emerging evidence supports the notion of interplay between uptake and efflux drug transport as the determinants that define the extent of exposure of many drugs and their CNS action.

OBJECTIVE:

In this brief report, we review a number of key drug transporters known to be expressed at the blood-brain barrier and/or choroid plexus and focus on the implications of such transporters to CNS drug activity, side effects, andtoxicity. Specifically, this report focuses on the uptake transporters OATP1A2 (organic anion-transporting polypeptide 1A2) and MCT1 (monocarboxylate transporter 1), which are known to have substrates that are either neuroactive or known to result in CNS side effects and/or toxicity. Furthermore, the efflux transporters P-gp (P-gp; MDR1/ABCB1), BCRP (breast-cancer-resistance protein), OAT3 (organic anion transporter 3), and MRP4 (multidrug-resistance-associated protein 4) are also reviewed.

PMID:
19727692
DOI:
10.1007/s00228-009-0714-8
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center